These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22624424)

  • 21. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
    Foster J; Brewer C; Steele T
    Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voucher-based reinforcement of opiate abstinence during methadone detoxification.
    Robles E; Stitzer ML; Strain EC; Bigelow GE; Silverman K
    Drug Alcohol Depend; 2002 Jan; 65(2):179-89. PubMed ID: 11772479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.
    Naderi-Heiden A; Naderi A; Naderi MM; Rahmani-Didar F; Salimi AR; Gleiss A; Kasper S; Frey R
    Pharmacopsychiatry; 2010 Jun; 43(4):130-7. PubMed ID: 20101570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic treatment with methadone and naltrexone on sleep in addicts.
    Staedt J; Wassmuth F; Stoppe G; Hajak G; Rodenbeck A; Poser W; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(6):305-9. PubMed ID: 8908412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
    Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten Years of Abstinence in Former Opiate Addicts: Medication-Free Non-Patients Compared to Methadone Maintenance Patients.
    Peles E; Sason A; Tene O; Domany Y; Schreiber S; Adelson M
    J Addict Dis; 2015; 34(4):284-95. PubMed ID: 26284418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term course of opioid addiction.
    Hser YI; Evans E; Grella C; Ling W; Anglin D
    Harv Rev Psychiatry; 2015; 23(2):76-89. PubMed ID: 25747921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with relapse among opiate addicts in an out-patient detoxification programme.
    Unnithan S; Gossop M; Strang J
    Br J Psychiatry; 1992 Nov; 161():654-7. PubMed ID: 1422615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does naltrexone affect craving in abstinent opioid-dependent patients?
    Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
    Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.
    Hser YI; Li J; Jiang H; Zhang R; Du J; Zhang C; Zhang B; Evans E; Wu F; Chang YJ; Peng C; Huang D; Stitzer ML; Roll J; Zhao M
    Addiction; 2011 Oct; 106(10):1801-9. PubMed ID: 21793958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opiate detoxification protocols. A clinical manual.
    Fishbain DA; Rosomoff HL; Cutler R
    Ann Clin Psychiatry; 1993 Mar; 5(1):53-65. PubMed ID: 8394176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice.
    Merlo LJ; Greene WM; Pomm R
    J Addict Med; 2011 Dec; 5(4):279-83. PubMed ID: 22107877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).
    Nordmann S; Lions C; Vilotitch A; Michel L; Mora M; Spire B; Maradan G; Morel A; Roux P; Carrieri MP;
    Psychopharmacology (Berl); 2016 Apr; 233(7):1203-13. PubMed ID: 26753792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Simon DL
    Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
    [No Abstract]   [Full Text] [Related]  

  • 36. What you need to know: addiction--prescribing naltrexone.
    Yeo BK
    Singapore Med J; 1997 Feb; 38(2):92-3. PubMed ID: 9269372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotherapy/counseling for opiate addicts: strategies for use in different treatment settings.
    Rounsaville BJ; Kleber HD
    Int J Addict; 1985; 20(6-7):869-96. PubMed ID: 3908340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation between opiate addicts in relation to judicial problems.
    Vasić G; Mihajlović G; Jovanović-Mihajlović N; Rafajlović M; Barisić J; Djukić-Dejanović S; Janković S; Radonjić K
    Srp Arh Celok Lek; 2011 Dec; 139 Suppl 1():52-6. PubMed ID: 22352204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome.
    Rounsaville BJ; Weissman MM; Crits-Christoph K; Wilber C; Kleber H
    Arch Gen Psychiatry; 1982 Feb; 39(2):151-6. PubMed ID: 7065829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.